List of insiders holdings for Taysha Gene Therapies Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| 1 | Manning Paul B 10% Owner | 2025-06-03 21:54:54 | 25,601,111 0 | 25,601,111 | Form 13D |
| 2 | Session R.A. II 10% Owner | 2023-07-14 16:00:39 | 8,871,747 282,180 | 9,153,927 | Form 4 |
| 3 | Audentes Therapeutics Inc. Astellas Pharma Inc. 10% Owner | 2023-08-18 17:16:27 | 7,266,342 0 | 7,266,342 | Form 13D |
| 4 | Nolan Sean P. Chief Executive Officer | 2025-01-03 17:38:40 | 2,970,858 1,535,545 | 4,506,403 | Form 4 |
| 5 | Stalfort John A III Director | 2025-06-04 16:15:26 | 1,268,470 884,290 | 2,152,760 | Form 4 |
| 6 | Nagendran Sukumar President and Head of R&D | 2025-01-03 17:36:40 | 1,546,843 0 | 1,546,843 | Form 4 |
| 7 | PRASAD SUYASH CMO and Head of R&D | 2022-07-07 16:30:28 | 530,589 0 | 530,589 | Form 4 |
| 8 | Donenberg Phillip B. Director | 2025-06-04 16:15:20 | 333,200 0 | 333,200 | Form 4 |
| 9 | Long Alison S Director | 2025-06-04 16:15:15 | 219,089 0 | 219,089 | Form 4 |
| 10 | Sepp-Lorenzino Laura Director | 2025-06-04 16:15:11 | 219,089 0 | 219,089 | Form 4 |
| 11 | Reape Kathleen Director | 2023-06-26 16:50:09 | 36,200 0 | 36,200 | Form 4 |
| 12 | Alam Kamran CHIEF FINANCIAL OFFICER | 2025-04-10 16:15:13 | 12,462 0 | 12,462 | Form 4/A |